November 2017: Prescribing in pregnancy - stop stopping and start planning

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the challenges associated with prescribing for long-term conditions in women who are pregnant and raise concerns that medicines may be stopped inappropriately. Read the editorial here: http://dtb.bmj.com/content/55/11/121. The editors also review a combination product containing naltrexone and bupropion that is licensed for the management of obesity - http://dtb.bmj.com/content/55/11/126 - and discuss bleeding risks associated with direct oral anticoagulants (DOACs)- http://dtb.bmj.com/content/55/11/129. http://dtb.bmj.com/